Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
Toll-like receptors (TLRs) are natural initial triggers of innate and adaptive immune responses. With the advent of cancer immunotherapy, nucleic acids engineered as ligands of endosomal TLRs have been investigated for the treatment of solid tumors. Despite promising results, their systemic administ...
Main Authors: | Fernando Torres Andón, Sergio Leon, Aldo Ummarino, Esther Redin, Paola Allavena, Diego Serrano, Clément Anfray, Alfonso Calvo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/7/1590 |
Similar Items
-
Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
by: Graham Thomas, et al.
Published: (2021-07-01) -
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022-06-01) -
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01) -
Immunotherapeutic Agents for Intratumoral Immunotherapy
by: Chih-Rong Shyr, et al.
Published: (2023-11-01) -
Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
by: Alexis A. Hatton, et al.
Published: (2022-12-01)